Cargando…
Evidence-based point-of-care technology development during the COVID-19 pandemic
Since December 2019, the SARS-CoV-2 outbreak that began in Wuhan, China has spread to nearly every continent and become a global health concern. Although much has been discovered about COVID-19 and its pathogenesis, the WHO has identified an immediate need to increase the levels of testing for COVID...
Autores principales: | Parupudi, Tejasvi, Panchagnula, Neha, Muthukumar, Sriram, Prasad, Shalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651990/ https://www.ncbi.nlm.nih.gov/pubmed/33161729 http://dx.doi.org/10.2144/btn-2020-0096 |
Ejemplares similares
-
Next-Generation Continuous Metabolite Sensing toward
Emerging Sensor Needs
por: Bhide, Ashlesha, et al.
Publicado: (2021) -
Emerging Electrochemical Biosensing Trends for Rapid
Diagnosis of COVID-19 Biomarkers as Point-of-Care Platforms: A Critical
Review
por: Madhurantakam, Sasya, et al.
Publicado: (2022) -
Ultrasensitive and low-volume point-of-care diagnostics on flexible strips – a study with cardiac troponin biomarkers
por: Shanmugam, Nandhinee Radha, et al.
Publicado: (2016) -
Establish pre-clinical diagnostic efficacy for parathyroid hormone as a point-of-surgery-testing-device (POST)
por: Tanak, Ambalika S., et al.
Publicado: (2020) -
Multiplexed cytokine detection using electrochemical point-of-care sensing device towards rapid sepsis endotyping
por: Tanak, Ambalika S., et al.
Publicado: (2021)